Interesting. If I am reading this report correctly, these guys...

First 15 Last

Share
Profile

Follow
sailnyssa

604 Posts.

292

18/09/18

06:51

Post #: 35659682
Share

Originally posted by roka ↑

H.C. WAINWRIGHT & CO
11 September 2018
It's All BNC210: KOL Focus on Agitation; Major PTSD Catalyst This Month
https://www.bionomics.com.au/upload/investors/analyst-coverage/35183/HC Wainwright 11 September 2018.pdf
Significant events could progress rapidly for Bionomics, led by a potential major partnership or takeout. We are also taking this opportunity to remind investors about a major upcoming catalyst expected in September, namely the readout of Phase 2 'restore' study with BNC210 in PTSD patients. Based on clinical activity to date, including the positive randomized Phase 2 in generalized anxiety disorder (GAD), we project a successful outcome in the PTSD, which is assessing a broad set of metrics. Further, we highlight what we anticipate could be a quite rapid culmination of the business development discussions that have been ongoing for BNC210. Having a new potential drug for PTSD and other neuropsych indications with a novel and safe mechanism of action represents a strong potential advantage to pharma players. We also reiterate our view that Merck (MRK; not rated) could be a likely choice for this partnership (or even acquisition). Recall that Merck has already signed two major partnerships with Bionomics for pain and cognition. While Merck does not have any agreement for BNC210, we believe it should be an easy choice since a productive relationship is already in place. Our overall recommendation remains consistent, we reiterate our Buy rating Bionomics ahead of these catalysts.

Expand

Interesting. If I am reading this report correctly, these guys are forecasting negative earnings per share through to 2021 -- their P&L doesn't extend beyond this.The $2.00 target has been pulled out of the air. I'd rely on my own research ahead of this type of sponsored research.

BNO Price at posting: 51.0¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

HotCopper Highlights: Your most watched and most discussed stocks this week

Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive

MMI

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?

UBI

Universal Biosensors flat despite fresh deal with US medical product distributor

Trump is President Again: What Does This Mean for Crypto?

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

IMU

Imugene kicks off Australian trial for blood cancer treatment

FG1

Flynn Gold reaches milestone exploration target for Golden Ridge